{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:24:32Z","timestamp":1787009072535,"version":"build-2736575974"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["75N95019C00016"],"award-info":[{"award-number":["75N95019C00016"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["75N95024C00014"],"award-info":[{"award-number":["75N95024C00014"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA057351"],"award-info":[{"award-number":["R01 DA057351"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017908","name":"ALSAM Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017908","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cannabis consumption has and continues to increase dramatically, as does its legalization for recreational and\/or medicinal use at the state, but not at the federal level. The increased consumption and legalization have spurred significant cannabis focused research, with particular interest in defining the pharmacokinetic characteristics of this complex natural product. Supporting this research requires a bioanalytical method that accurately and simultaneously quantifies the primary cannabinoids and their metabolites. The objective of this method validation was to meet pre-specified sensitivity targets (0.5\u2009ng\/mL for most analytes) from a low sample volume (0.2\u2009mL) and a single extraction approach that could quantify \u03949-tetrahydrocannabinol, cannabidiol, and their metabolites. Moreover, we sought to rigorously characterize the stability of included cannabinoid analytes, both in solution and plasma. The developed assay required optimization of extraction and mobile phase solvents, as well as mass transitions to achieve the selectivity required to meet the desired sensitivity targets. Stability experiments indicated solution stability of no more than 6\u2009months when stored in polypropylene at \u221230 or \u221280\u00b0C and \u223c3\u2009years (34.5\u2009months) of plasma stability when stored in polypropylene at \u221280\u00b0C. The assay was successfully applied to \u223c1650 samples without a batch failure. This validated LC\u2013MS\/MS assay provides unique information on cannabinoid stability and has been utilized to generate novel data on the pharmacokinetics of cannabis constituents and their metabolites.<\/jats:p>","DOI":"10.1093\/jat\/bkaf087","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T11:53:43Z","timestamp":1757678023000},"source":"Crossref","is-referenced-by-count":3,"title":["Analysis of seven selected cannabinoids in human plasma highlighting matrix and solution stability assessments"],"prefix":"10.1093","volume":"50","author":[{"given":"David J","family":"Anderson","sequence":"first","affiliation":[{"name":"Center for Human Toxicology and Department of Pharmacology and Toxicology, University of Utah , Salt Lake City, UT 84112,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tia S","family":"Freeman","sequence":"additional","affiliation":[{"name":"Center for Human Toxicology and Department of Pharmacology and Toxicology, University of Utah , Salt Lake City, UT 84112,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalii S","family":"Caldwell","sequence":"additional","affiliation":[{"name":"Center for Human Toxicology and Department of Pharmacology and Toxicology, University of Utah , Salt Lake City, UT 84112,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan R","family":"Hoggard","sequence":"additional","affiliation":[{"name":"Center for Human Toxicology and Department of Pharmacology and Toxicology, University of Utah , Salt Lake City, UT 84112,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A","family":"Reilly","sequence":"additional","affiliation":[{"name":"Center for Human Toxicology and Department of Pharmacology and Toxicology, University of Utah , Salt Lake City, UT 84112,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3629-7902","authenticated-orcid":false,"given":"Joseph E","family":"Rower","sequence":"additional","affiliation":[{"name":"Center for Human Toxicology and Department of Pharmacology and Toxicology, University of Utah , Salt Lake City, UT 84112,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"2026042220281489000_bkaf087-B1","author":"DISA Global Solutions"},{"key":"2026042220281489000_bkaf087-B2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jat\/19.5.285","article-title":"Cannabinoids in humans. I. Analysis of \u03949-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS","volume":"19","author":"Kemp","year":"1995","journal-title":"J Anal Toxicol"},{"key":"2026042220281489000_bkaf087-B3","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/jat\/29.8.782","article-title":"Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract","volume":"29","author":"Nadulski","year":"2005","journal-title":"J Anal Toxicol"},{"key":"2026042220281489000_bkaf087-B4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jat\/24.6.395","article-title":"Simultaneous analysis of \u03949-THC and its major metabolites in urine, plasma, and meconium by GC-MS using an immunoaffinity extraction procedure","volume":"24","author":"Feng","year":"2000","journal-title":"J Anal Toxicol"},{"key":"2026042220281489000_bkaf087-B5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.chroma.2019.01.041","article-title":"First application of atmospheric-pressure chemical ionization gas chromatography tandem mass spectrometry to the determination of cannabinoids in serum","volume":"1591","author":"Gottardo","year":"2019","journal-title":"J Chromatogr A"},{"key":"2026042220281489000_bkaf087-B6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.forsciint.2018.06.003","article-title":"A fast and reliable method for quantitation of THC and its 2 main metabolites in whole blood by GC\u2013MS\/MS (TQD)","volume":"289","author":"Castro","year":"2018","journal-title":"Forensic Sci Int"},{"key":"2026042220281489000_bkaf087-B7","first-page":"277","article-title":"Determination of\u0394-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and cannabidiol in human plasma using gas chromatography\u2013tandem mass spectrometry","volume":"41","author":"Andrenyak","year":"2017","journal-title":"J Anal Toxicol"},{"key":"2026042220281489000_bkaf087-B8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.forsciint.2006.03.033","article-title":"Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dr\u00e4ger DrugTest","volume":"161","author":"Laloup","year":"2006","journal-title":"Forensic Sci Int"},{"key":"2026042220281489000_bkaf087-B9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jchromb.2006.12.045","article-title":"Development of a LC\/MS\/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts","volume":"850","author":"Grauwiler","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2026042220281489000_bkaf087-B10","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00216-012-6501-x","article-title":"Simultaneous and sensitive LC-MS\/MS determination of tetrahydrocannabinol and metabolites in human plasma","volume":"405","author":"Ferreir\u00f3s","year":"2013","journal-title":"Anal Bioanal Chem"},{"key":"2026042220281489000_bkaf087-B11","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.4155\/bio-2018-0184","article-title":"A UHPLC-MS\/MS method for the quantification of \u03949-tetrahydrocannabinol and cannabidiol in decoctions and in plasma samples for therapeutic monitoring of medical cannabis","volume":"10","author":"Barco","year":"2018","journal-title":"Bioanalysis"},{"key":"2026042220281489000_bkaf087-B12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1089\/can.2018.0075","article-title":"Fast and sensitive quantification of \u0394(9)-tetrahydrocannabinol and its main oxidative metabolites by liquid chromatography\/tandem mass spectrometry","volume":"4","author":"Vozella","year":"2019","journal-title":"Cannabis Cannabinoid Res"},{"key":"2026042220281489000_bkaf087-B13","doi-asserted-by":"publisher","first-page":"e4952","DOI":"10.1002\/bmc.4952","article-title":"Determination of cannabinoids in plasma using salting-out-assisted liquid-liquid extraction followed by LC-MS\/MS analysis","volume":"34","author":"da Silva","year":"2020","journal-title":"Biomed Chromatogr"},{"key":"2026042220281489000_bkaf087-B14","author":"Food and Drug Administration","year":"2020"},{"key":"2026042220281489000_bkaf087-B15","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/clinchem\/hvaa113","article-title":"Identifying and quantifying cannabinoids in biological matrices in the medical and legal cannabis era","volume":"66","author":"Karschner","year":"2020","journal-title":"Clin Chem"},{"key":"2026042220281489000_bkaf087-B16","doi-asserted-by":"crossref","first-page":"1038754","DOI":"10.3389\/fphar.2022.1038754","article-title":"Cannabidiol,\u0394 9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS\/MS following controlled administration in epilepsy patients","volume":"13","author":"Pigliasco","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026042220281489000_bkaf087-B17","doi-asserted-by":"crossref","first-page":"105705","DOI":"10.1016\/j.ejps.2021.105705","article-title":"Development and validation of a LC-HRMS method for the quantification of cannabinoids and their metabolites in human plasma","volume":"159","author":"Mohamed","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"2026042220281489000_bkaf087-B18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/dta.2947","article-title":"A validated method for the simultaneous quantification of cannabidiol, \u03949-tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial","volume":"13","author":"Kevin","year":"2021","journal-title":"Drug Test Anal"},{"key":"2026042220281489000_bkaf087-B19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jat\/bkab030","article-title":"Simultaneous quantification of 17 cannabinoids by LC\u2013MS-MS in human plasma","volume":"46","author":"Sempio","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026042220281489000_bkaf087-B20","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1111\/epi.18104","article-title":"Utilizing an acute hyperthermia-induced seizure test and pharmacokinetic studies to establish optimal dosing regimens in a mouse model of Dravet syndrome","volume":"65","author":"Mensah","year":"2024","journal-title":"Epilepsia"},{"key":"2026042220281489000_bkaf087-B21","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1373\/clinchem.2012.201467","article-title":"In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis","volume":"59","author":"Scheidweiler","year":"2013","journal-title":"Clin Chem"},{"key":"2026042220281489000_bkaf087-B22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/jat\/bkz073","article-title":"Cannabinoid Stability in Antemortem and Postmortem Blood","volume":"44","author":"Meneses","year":"2020","journal-title":"J Anal Toxicol"},{"key":"2026042220281489000_bkaf087-B23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jat\/19.6.483","article-title":"Quantitative analysis of THC, 11-OH-THC, and THCCOOH in human hair by negative ion chemical ionization mass spectrometry","volume":"19","author":"Wilkins","year":"1995","journal-title":"J Anal Toxicol"},{"key":"2026042220281489000_bkaf087-B24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0379-0738(01)00538-2","article-title":"\u03949-THC, 11-OH-\u03949-THC and \u03949-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people","volume":"123","author":"Giroud","year":"2001","journal-title":"Forensic Sci Int"},{"key":"2026042220281489000_bkaf087-B25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jat\/bkac007","article-title":"An enhanced LC\u2013MS-MS technique for distinguishing \u03948-and \u03949-tetrahydrocannabinol isomers in blood and urine specimens","volume":"46","author":"Reber","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026042220281489000_bkaf087-B26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/ftd.0000000000000427","article-title":"An atmospheric pressure chemical ionization MS\/MS assay using online extraction for the analysis of 11 cannabinoids and metabolites in human plasma and urine","volume":"39","author":"Klawitter","year":"2017","journal-title":"Ther Drug Monit"},{"key":"2026042220281489000_bkaf087-B27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jchromb.2019.03.002","article-title":"Development and validation of an assay to measure cannabidiol and \u03949-tetrahydrocannabinol in human EDTA plasma by UHPLC-MS\/MS","volume":"1112","author":"Ocque","year":"2019","journal-title":"J Chromatogr B"},{"key":"2026042220281489000_bkaf087-B28","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/dta.3631","article-title":"Prevalence of carboxy-\u03948-tetrahydrocannabiniol in antidoping samples","volume":"16","author":"Nair","year":"2024","journal-title":"Drug Test Anal"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkaf087\/64286735\/bkaf087.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/2\/bkaf087\/64286735\/bkaf087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/2\/bkaf087\/64286735\/bkaf087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:28:21Z","timestamp":1776904101000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/doi\/10.1093\/jat\/bkaf087\/8255970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4,22]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkaf087","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,9,16]]},"article-number":"bkaf087"}}